Answers are grounded in this paper and cite their sources.
One-step synthesis yields CsSrCl₃:Eu nanocrystals with 40% quantum yield, suggesting effective self-reduction and stability enhancement.
Europium halide perovskites have emerged as promising candidates for environmental-friendly blue-emitting materials. However, their development is hindered by relative low photoluminescence quantum yields (PLQY, e.g. ~2-5% for intrinsic CsEuCl3) and poor stability against air. Here, we introduce a one-step-procedure for synthesizing Eu²⁺-doped CsSrCl₃ large nanocrystal clusters (LNCs) with the effect of self-reduction, therefore eliminating the use of conventional reductant oleylamine (OAm) and ensuring phase purity. The CsSrCl₃:Eu LNCs shows photoluminescence emission centered at 430 nm with a full width at half-maximum (FWHM) of 25 nm and a PLQY of ~40%, which can be further enhanced to ~97% after passivating the surface defects by adding trioctylphosphine (TOP), the highest among all reported lead-free blue-emitting perovskite nanocrystals. The stability of CsSrCl₃:Eu can also be improved significantly by epitaxially growing ZnS shell on the surface. This work will shed more light on lanthanide and alkaline-earth metal (AEM)-based perovskites for nontoxic light-emitting materials.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: